Table 4.
Infants | Toddlers | Children | Adolescents | Adults | The elderly | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
(12 weeks–11 months) | (12–35 months) | (3–9 years) | (10–17 years) | (18–64 years) | (≥ 65 years) | |||||||
Min | Max | Min | Max | Min | Max | Min | Max | Min | Max | Min | Max | |
Regulatory maximum level exposure assessment scenario | ||||||||||||
Mean | 0 | 0.22 | 0.02 | 1.17 | 0.10 | 1.40 | 0.15 | 1.08 | 0.07 | 0.47 | 0.04 | 0.16 |
95th percentile | 0 | 1.40 | 0.13 | 4.31 | 0.50 | 3.60 | 0.61 | 2.61 | 0.32 | 1.70 | 0.15 | 0.64 |
Refined estimated exposure assessment scenario | ||||||||||||
Brand‐loyal scenario | ||||||||||||
Mean | 0 | 0.2 | 0.02 | 1.07 | 0.09 | 1.01 | 0.14 | 0.77 | 0.06 | 0.36 | 0.03 | 0.10 |
95th percentile | 0 | 1.32 | 0.10 | 4.06 | 0.46 | 3.24 | 0.58 | 2.04 | 0.3 | 1.39 | 0.13 | 0.42 |
Non‐brand‐loyal scenario | ||||||||||||
Mean | 0 | 0.08 | 0.01 | 0.44 | 0.05 | 0.48 | 0.07 | 0.37 | 0.03 | 0.16 | 0.02 | 0.06 |
95th percentile | 0 | 0.51 | 0.09 | 1.59 | 0.25 | 1.28 | 0.27 | 0.89 | 0.14 | 0.59 | 0.09 | 0.23 |